title: T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.
abstract: Although genes play a major role in the etiology of schizophrenia, no major genes involved in this disease have been identified. However, several genes with small effect have been reported, though inconsistently, to increase the risk for schizophrenia. Recently, the 5HT2A 2 allele (T102C polymorphism) was reported to be over-represented in patients with schizophrenia. Other reports have found an excess of allele 2(C) only in schizophrenic patients who are resistant to clozapine, not in those who respond to clozapine. In this study, the 5HT2A receptor allele 2 frequencies were compared between 2 groups of patients with schizophrenia (39 responders and 63 nonresponders) based on long-term outcome and response to typical neuroleptics. A control group of 90 healthy volunteers screened for mental disorders was also included. Genotype 2/2 tended to be more frequent in patients with schizophrenia with poor long-term outcome and poor response to typical neuroleptics (Bonferroni corrected p = 0.09). This difference was significant in men (Bonferroni corrected p = 0.054) but not in women. In addition, the age at first contact with psychiatric care was significantly younger in the patients with schizophrenia with genotype 2/2 than in patients with genotype 1/1. These result suggest that the 5HT2A-receptor gene may play a role in a subset of schizophrenia characterized by poor long-term outcome and poor response to neuroleptics.
authors.affiliation: Montreal General Hospital Research Institute, Douglas Hospital Research Centre, Verdun QC. rjoobe@po-box.mcgill.ca
authors.forename: R
authors.initials: R
authors.lastname: Joober
authors.forename: C
authors.initials: C
authors.lastname: Benkelfat
authors.forename: K
authors.initials: K
authors.lastname: Brisebois
authors.forename: A
authors.initials: A
authors.lastname: Toulouse
authors.forename: G
authors.initials: G
authors.lastname: Turecki
authors.forename: S
authors.initials: S
authors.lastname: Lal
authors.forename: D
authors.initials: D
authors.lastname: Bloom
authors.forename: A
authors.initials: A
authors.lastname: Labelle
authors.forename: P
authors.initials: P
authors.lastname: Lalonde
authors.forename: D
authors.initials: D
authors.lastname: Fortin
authors.forename: M
authors.initials: M
authors.lastname: Alda
authors.forename: R
authors.initials: R
authors.lastname: Palmour
authors.forename: G A
authors.initials: GA
authors.lastname: Rouleau
mesh_terms: D000328:Adult; D000483:Alleles; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011110:Polymorphism, Genetic; D044402:Receptor, Serotonin, 5-HT2A; D011985:Receptors, Serotonin / Q000187:drug effects / Q000235:genetics*; D012559:Schizophrenia / Q000235:genetics*
chemical_list: D044402:Receptor, Serotonin, 5-HT2A; D011985:Receptors, Serotonin